BORA PHARMACEUTICALS LTD Total Liabilities

Latest as of March 2026: NT$28.70 Billion TWD ≈ $904.30 Million USD

BORA PHARMACEUTICALS LTD total liabilities. Based on the latest financial reports, BORA PHARMACEUTICALS LTD (6472) has total liabilities worth NT$28.70 Billion TWD (≈ $904.30 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of BORA PHARMACEUTICALS LTD to evaluate the company's liquid asset resilience ratio.

Total Liabilities of BORA PHARMACEUTICALS LTD (2019–2025)

Total liabilities of BORA PHARMACEUTICALS LTD from 2019 to 2025. This chart illustrates how BORA PHARMACEUTICALS LTD's total liabilities have evolved over time, based on quarterly financial data.

BORA PHARMACEUTICALS LTD Competitors by Total Liabilities

The table below lists competitors of BORA PHARMACEUTICALS LTD ranked by their total liabilities.

Company	Country	Total Liabilities
IBI Inv House TA:IBI	Israel	ILA972.93 Million
Farglory Land Development Co Ltd TW:5522	Taiwan	NT$64.70 Billion
agilon health Inc NYSE:AGL	USA	$1.36 Billion
Jiangsu New Energy Development Co Ltd SHG:603693	China	CN¥9.59 Billion
Galecto Inc NASDAQ:GLTO	USA	$25.18 Million
Shaily Engineering Plastics Limited NSE:SHAILY	India	Rs4.30 Billion
Ganfeng Lithium Co. Ltd F:39EA	Germany	€65.69 Billion
SASA Polyester Sanayi AS IS:SASA	Turkey	TL150.95 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down BORA PHARMACEUTICALS LTD's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 6472 asset base.

Liquidity & Leverage Metrics

BORA PHARMACEUTICALS LTD Total Liabilities Ratios Explained

BORA PHARMACEUTICALS LTD total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.38	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.97	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.63	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BORA PHARMACEUTICALS LTD's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BORA PHARMACEUTICALS LTD (2019–2025)

The table below shows the annual total liabilities of BORA PHARMACEUTICALS LTD from 2019 to 2025.

Year	Total Liabilities	Change
2025-09-30	NT$27.24 Billion ≈ $858.27 Million	-10.94%
2024-09-30	NT$30.59 Billion ≈ $963.67 Million	+130.22%
2023-09-30	NT$13.29 Billion ≈ $418.59 Million	-24.60%
2022-09-30	NT$17.62 Billion ≈ $555.15 Million	+317.57%
2021-09-30	NT$4.22 Billion ≈ $132.95 Million	-7.04%
2020-09-30	NT$4.54 Billion ≈ $143.02 Million	+162.56%
2019-09-30	NT$1.73 Billion ≈ $54.47 Million	--

About BORA PHARMACEUTICALS LTD

TW:6472 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$1.47 Billion

NT$46.78 Billion TWD

Market Cap Rank

#7020 Global

#217 in Taiwan

Share Price

NT$367.50

Change (1 day)

+0.55%

52-Week Range

NT$336.00 - NT$641.00

All Time High

NT$940.36